Dr. Paul R. Kunk, MD
- Medicare services, 2024
- 877
- Medicare patients, 2024
- 199
- Part D claims, 2024
- 529
- Publications
- 17
- Clinical trials
- 4
- Practice address
- 1240 Lee St,, Charlottesville, VA 22903
- Practice phone
- Call (434) 243-4704
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Emily Couric Clinical Cancer Center
Mammography / Breast Imaging Center · Charlottesville, Virginia
Find Dr. Kunk's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Paul R. Kunk is a medical oncologist in Charlottesville, Virginia
Dr. Kunk practices at Emily Couric Clinical Cancer Center in Charlottesville, Virginia.
Dr. Kunk's NPI, 1750671756, was assigned on April 11, 2011. Dr. Kunk holds Virginia license 0101258510.
- NPI
- 1750671756NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0244467454
- NPI enumeration date
- April 11, 2011
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (434) 243-4704
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 41
- Medical school graduation
- 2011
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Paul R. Kunk practices at Emily Couric Clinical Cancer Center in Charlottesville, Virginia
Dr. Kunk's primary practice is Emily Couric Clinical Cancer Center, at 1240 Lee St,, Charlottesville, VA 22903. The practice phone is (434) 243-4704.
- Emily Couric Clinical Cancer Center1240 Lee St,, Charlottesville, VA 22903Phone(434) 243-4704
Source: Dmand AI Affiliation Data
Dr. Paul R. Kunk is affiliated with 6 sites of care and 1 medical group
Dr. Kunk's primary practice is Emily Couric Clinical Cancer Center in Charlottesville, Virginia. Dr. Kunk is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Kunk to 3 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Kunk's employer is on file too: a breast imaging center.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Paul R. Kunk's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kunk practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Emily Couric Clinical Cancer Center | Available with a free account |
| +5 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Paul R. Kunk is one of 99 medical oncologists in Virginia
Medical oncology is Dr. Kunk's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kunk is licensed in Virginia.
Specialties and state licenses
- Medical oncology, VirginiaPrimary
Medical oncologists near Dr. Kunk
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Paul R. Kunk billed Medicare for 877 services in 2024
CMS data shows 877 Medicare services from Dr. Kunk across 7 procedure codes in 2024, for 199 Medicare patients. Medicare paid $57,335 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Kunk's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 5642024: 5571%
- Other services
- 2023: 02024: 320
Dr. Kunk compared with the Virginia median for medical oncologists, 2024
- Dr. Kunk
- Virginia median
- Medicare services
- 877vs 56655% above
- Medicare patients
- 199vs 22210% below
- Part D claims
- 345vs 30314% above
Medians across 96 medical oncologists in Virginia with Dmand AI profiles that report each measure.
Dr. Kunk's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kunk?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kunk and other medical oncologists in Virginia.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Paul R. Kunk treated 199 Medicare patients in 2024, average age 73
CMS counts 199 Medicare patients who saw Dr. Kunk in 2024. The largest group is 65 to 74, with 107 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Kunk's median patient age at 67, with 46% women.
Dr. Kunk's Medicare patients by age, 2024
Dr. Kunk's Medicare patients by sex, 2024
- Women8945%
- Men11055%
Chronic conditions among Dr. Kunk's Medicare patients, 2024
- High blood pressure75%
- High cholesterol67%
- Cancer48%
- Arthritis41%
- Diabetes36%
- Ischemic heart disease28%
- Chronic kidney disease27%
- Anxiety25%
Share of Medicare patients with each condition. A patient can have several.
Dr. Kunk's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women46%
- Men54%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Paul R. Kunk wrote 529 Medicare Part D claims in 2024
In 2024, Dr. Kunk wrote 529 Medicare Part D claims for 95 patients. 82% of them were for generic drugs. CMS names the drug for 345 of them, across 10 drugs with 11 or more claims each, at $86,060 in total drug cost. In 2023, CMS named 184 claims across 10 drugs.
Dr. Kunk's Part D claims by kind of drug, 2024
- Generic432 claims82%
- Brand-name97 claims18%
Dr. Kunk's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Kunk's Part D claims, 2024
- Opioids8%44 of 529 claims
- Antibiotics3%17 of 529 claims
- Antipsychotics, patients 65 and over8%44 of 529 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1842024: 34588%
Drugs named by CMS: 10 in 2024, 10 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Paul R. Kunk scored 86 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Kunk for performance year 2024, reported as part of a group. Dr. Kunk accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kunk as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Kunk's MIPS scores, performance year 2024
- 86of 100Final score
- 79.8of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 75of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Paul R. Kunk has 17 publications on record
Dmand AI links 17 papers to Dr. Kunk, published from 2015 to 2025. 2016 was the busiest year, with 3. The most frequent topics are Antibodies, Monoclonal, Humanized, Anticoagulants and Antineoplastic Combined Chemotherapy Protocols. Dr. Kunk has published most often in J Immunother Cancer. Dr. Kunk's most frequent co-authors are Osama E. Rahma, MD, Craig L. Slingluff, MD and Todd W. Bauer, MD.
Dr. Kunk's papers by year, 2015 to 2025
Topics Dr. Kunk writes about most
- Antibodies, Monoclonal, Humanized
- Anticoagulants
- Antineoplastic Combined Chemotherapy Protocols
- B7-H1 Antigen
- Bile Duct Neoplasms
- Cholangiocarcinoma
- Hemorrhage
- Piperidines
Dr. Kunk's most frequent co-authors
- Osama E. Rahma, MD6 shared papers
- Craig L. Slingluff, MD5 shared papers
- Todd W. Bauer, MD4 shared papers
Recent publications by Dr. Kunk
See who Dr. Kunk researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kunk works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Paul R. Kunk has worked on 4 clinical trials
Dmand AI links Dr. Kunk to 4 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Gallbladder Neoplasms, Gallbladder Diseases and Pancreatic Neoplasms. National Cancer Institute (NCI) sponsors the most, 2.
Clinical trials with Dr. Kunk by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Kunk's trials
- Gallbladder Neoplasms
- Gallbladder Diseases
- Pancreatic Neoplasms
- Pancreatic Diseases
Investigators on the most trials with Dr. Kunk
Recent clinical trials with Dr. Kunk
A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Paul R. Kunk received $8,578 in industry payments from 2018 to 2025
CMS Open Payments shows 14 general payments to Dr. Kunk from 6 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. Exelixis Inc. paid the most, $5,466. It also lists 2 research payments totaling $6,400 from 2021 to 2022.
General payments to Dr. Kunk by program year, 2018 to 2025
General payments to Dr. Kunk by kind, 2018 to 2025
- Speaker and faculty fees$5,82068%
- Travel and lodging$2,05524%
- Food and beverage$7038%
Companies that paid Dr. Kunk the most, 2018 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Paul R. Kunk's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Paul R. Kunk
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Paul R. Kunk's NPI number?
Dr. Paul R. Kunk's NPI number is 1750671756. It was assigned on April 11, 2011, and it is active in the NPI Registry.
What kind of doctor is Dr. Paul R. Kunk?
Dr. Paul R. Kunk is a medical oncologist in Charlottesville, Virginia. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Paul R. Kunk practice?
Dr. Kunk practices at 1240 Lee St,, Charlottesville, VA 22903. Dr. Kunk's primary practice is Emily Couric Clinical Cancer Center in Charlottesville, Virginia. Dmand AI also links Dr. Kunk to 3 hospitals and 1 group practice or clinic.
What is Dr. Paul R. Kunk's office phone number?
The practice phone on file for Dr. Kunk is (434) 243-4704.
What is Dr. Paul R. Kunk's medical license number?
Dr. Kunk holds Virginia license 0101258510.
Which hospitals is Dr. Paul R. Kunk affiliated with?
Dr. Kunk is affiliated with University Medical Center. Dmand AI links Dr. Kunk to 3 more hospitals.
What medical group is Dr. Paul R. Kunk part of?
Dr. Kunk is linked to UVA Physicians Group.
Does Dr. Paul R. Kunk accept Medicare?
Yes. CMS data shows Dr. Kunk billed Medicare for 877 services in 2024, and Dr. Kunk accepts Medicare assignment.
Does Dr. Paul R. Kunk offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Kunk as offering telehealth services.
What is Dr. Paul R. Kunk's MIPS score?
Dr. Kunk's MIPS final score for performance year 2024 is 86 out of 100, reported as part of a group.
Show 7 more questionsShow fewer questions
How many Medicare patients does Dr. Paul R. Kunk see?
CMS counts 199 Medicare patients who saw Dr. Kunk in 2024, with an average age of 73.
What services does Dr. Paul R. Kunk bill to Medicare?
In 2024, Dr. Kunk's most billed Medicare services were medicare service (G2211), office visit, established patient (99215) and office visit, established patient (99214).
What drugs does Dr. Paul R. Kunk prescribe most?
In 2024 Medicare Part D data, Dr. Kunk's most prescribed drugs by claims were Prochlorperazine Maleate, Ondansetron HCl and Olanzapine.
Has Dr. Paul R. Kunk received payments from drug or device companies?
CMS Open Payments shows $8,578 in general payments to Dr. Kunk from 6 companies from 2018 to 2025. The largest total came from Exelixis Inc.
How long has Dr. Paul R. Kunk been practicing?
Dr. Kunk graduated from medical school in 2011, 15 years ago.
Does Dr. Paul R. Kunk do research?
Dmand AI links 17 publications to Dr. Kunk, published from 2015 to 2025. Dr. Kunk has worked on 4 clinical trials.
Who does Dr. Paul R. Kunk publish with?
Dr. Kunk's most frequent co-authors are Osama E. Rahma, MD (6 shared papers), Craig L. Slingluff, MD (5 shared papers) and Todd W. Bauer, MD (4 shared papers).
Selling to medical oncology practices?
See medical oncologists in Virginia by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card